Incyte Biosciences United Kingdom & Ireland was established in 2016 and has been steadily growing since then. We have novel therapies in our R&D portfolio, and an experienced, growing team who have a shared goal to ensure UK & Ireland patients have access to first-in-class and best-in-class therapeutics to meet serious unmet medical needs in Haematology, Oncology and Inflammation and Autoimmunity.